Call for Abstract

11th Annual Conference on Stem Cell and Regenerative Medicine, will be organized around the theme “Cell in Progress: Exploring Regenerative medicine through Stem Cells”

Stem regenerative 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Stem regenerative 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Stem cells are those which are undifferentiated at the biological level and have an ability to divide (through mitosis) to produce many stem cells. They can be found in multicellular living organisms. In mammals, there are two broad types of stem cells: Embryonic and Adult stem cells. Embryonic Stem cells are also known as pluripotent stem cells isolated from the inner cell mass of blastocysts, where Adult stem cells are found in various tissues. The main function of stem cells and progenitor cells is to act as a repair system for the body, replenishing adult tissue.

  • Track 1-1Hematopoietic stem cells
  • Track 1-2Mammary stem cells
  • Track 1-3Intestinal stem cells
  • Track 1-4Mesenchymal stem cells
  • Track 1-5Endothelial stem cells
  • Track 1-6Neural stem cells
  • Track 1-7Olfactory adult stem cells
  • Track 1-8Neural crest stem cells
  • Track 1-9Testicular cells
  • Track 1-10Bone Marrow Stem Cells
  • Track 1-11Adipose (fat) Stem Cells

The process of “replacing tissues or organs, engineering or regenerating human cells to restore or establish normal function” is generally termed as Regenerative medicine. Regenerative medicine is a branch of Translational Research in the areas of tissue engineering and molecular biology. Regenerative medicine stimulates the body’s own repair mechanisms to engineer the damaged tissues and organs.

 

  • Track 2-1Cellular Engineering
  • Track 2-2Nuclear Reprogramming
  • Track 2-3Progenitor Cell Injection
  • Track 2-4Invitro Grown Organ Transplantation
  • Track 2-5Genetic Engineering
  • Track 2-6Functional Restoration
  • Track 2-7Physical Therapy Modalities
  • Track 2-8Regeneration in Humans
  • Track 2-9Molecular Biology Analysis
  • Track 2-10Kinematic Analysis

Bioprocessing is a technology used for transferring the current laboratory-based practice of stem cell tissue culture to the clinical research as therapeutics necessitates for the application of engineering principles and practices to achieve control, automation, safety, validation and reproducibility of the process and the product. Biobanks are the type of biorepositories which collects, processes, stores and distributes biospecimens to support future scientific investigation. This plays an important role in helping the researchers providing the background knowledge of the subject.

  • Track 3-1Cell Bioprocessing
  • Track 3-2Cell Isolation & Cultivation
  • Track 3-3Biological specimens
  • Track 3-4Genomic and genetic disorders biobank
  • Track 3-5Whole exon sequencing for rare disease
  • Track 3-6Vitiligo biobank

The anatomical region where stem cells are found in a shallow recess is referred to a stem-cell niche. It refers to a microenvironment with reference to the in vivo or in vitro stem cells; they even interact with stem cells to regulate cell fate. Various niche factors act on embryonic stem cells to induce their proliferation or differentiation for the development of the fetus and in altering the gene expression during the embryonic development. In the human body, stem cells maintain the adult stem cells in a dormancy state, but during the tissue injury it actively signals to stem cells to promote either self-renewal or differentiation to form a new tissue.

  • Track 4-1GSC niche in¬†Drosophila¬†ovaries
  • Track 4-2Molecular Mechanism of GSC
  • Track 4-3Molecular Signalling
  • Track 4-4Hematopoietic Stem Cell
  • Track 4-5Mesenchymal Stem Cell
  • Track 4-6Vertebrate Adult Stem Cell Niche
  • Track 4-7Cancer Stem Cell Niche
  • Track 4-8Atrial cardiac stem cells niche
  • Track 4-9Invivo Stem Cell Microenvironment
  • Track 4-10Embryonic Erythropoietic Niche
  • Track 4-11Injury Induced Stem Cell Niches
  • Track 4-12Induced Pluripotent Stem Cells
  • Track 4-13Extracellular Matrix Mimicking Strategies

Tissue regeneration is a branch of Regenerative medicine which deals with the study of regrowth or repair of the damaged or lost tissues in response to the injury. Non-injured tissues by default have expanded cells in the formation over time, but the new cells formed in response to the injury replaces the expanded cells in closing up the wounded site leaving a scar mark on the skin. For example, an injured cell is regenerated in 4-5 weeks, whereas a non-injured cell regenerates in just 3-4 days.

  • Track 5-1Trends Developed in Tissue Engineering
  • Track 5-2Rejuvenation-fight aging
  • Track 5-3Molecular Repair
  • Track 5-4Biological Tissue Substitutes
  • Track 5-5Bone Tissue Engineering

Embryonic Stem cell is a broad type of Stem cell, which is also known as pluripotent stem cells derived from the inner cell mass of blastocyst, an early stage of pre-implantation embryo. Human embryos consist of 50-150 cells when they reach the blastocyst stage in 4-5 days of post fertilization. The destruction of the blastocyst mainly results in the isolation of the embryoblast or inner cell mass, which ethically raises issues in the post-implantation stage of development whether embryos at the pre-implantation stage should be considered to have the same moral or legal status or not. 

  • Track 6-1Pluripotent Stem cell
  • Track 6-2Potential clinical use
  • Track 6-3Human embryonic stem cells as models of genetic disorders
  • Track 6-4Repair of DNA damage
  • Track 6-5Techniques and conditions for derivation and culture

The medical procedure in which the organ from an individual is made to remove and place in the other individual is referred as transplantation. In stem cell transplantation, the stem cells are made to remove first, a high dose of chemotherapy or radiation therapy is given to destroy diseased cells. The extracted stem cells are made to implant in the patient, where they produce new blood and immune cells replacing the cells destroyed by the treatment.

 

  • Track 7-1Autologous stem-cell transplantation
  • Track 7-2Syngeneic stem cell transplantation
  • Track 7-3Peripheral stem cell transplantation
  • Track 7-4Stem cell transplantation for articular cartilage repair
  • Track 7-5Allotransplantation
  • Track 7-6Soft Tissue Cell Replacements
  • Track 7-7Stem Leydig cells: Effective Treatment for Testosterone
  • Track 7-8Transplantation of Bone Marrow stem cell

The process of research or discover of a medicine for a disease is generally called as drug discovery. In contrast, patient specific drug discovery is a process of inventing a drug by considering the pros and cons and the anatomical conditions of the patient. The general medicine is discovered on the basis of the active ingredient from traditional remedies or serendipitous discovery. It can also be referred as personalized medicine, which separates patients into different categories.

  • Track 8-1Personalized Medicine
  • Track 8-2Pharmacogenomics
  • Track 8-3Pharmacogenitics & Individualized Therapy
  • Track 8-4Pharmacokinetics
  • Track 8-5Plant Derived Drugs

Biomedicine is a branch of medicine biology which deals with the study of biological and physiological principles to clinical practice. It can be related to many categories under the health care and biological related fields. Delivering of the drug to the body, biostatistical analysis, molecular medicine, and Nano medicine can be sub-categorized under Biomedicine. For example, the mechanism of delivering the drug describes the information about the drug being delivered in a biological concept.

  • Track 9-1Drug Delivery System
  • Track 9-2Quantitative Pharmacology
  • Track 9-3Biostatistics
  • Track 9-4Bioinformatics
  • Track 9-5Molecular Medicine
  • Track 9-6Nano medicine

Adult Stem cell is a broad type of stem cells, which exhibits an ability to divide or self-renew cells in an indefinite manner, to generate different types of cell of organs to form, from which they have been originated and potentially regenerating the entire organ from a large number of cells. There are no such controversial issues with scientific researches for the use of adult stem cells, unlike the embryonic stem cells.

  • Track 10-1Stem Cell Apoptosis
  • Track 10-2Multipotency Adult Stem Cell
  • Track 10-3Adult stem cells and cancer
  • Track 10-4Adult stem cell therapies
  • Track 10-5Clinical applications

Alterations in the cells, tissues or fluids of molecular, cellular or biochemical that are measured and evaluated to indicate normal processes like biological, pathogenic or pharmacologic, which responses to a therapeutic interventions is defined as biomarkers or biological markers. Biomarkers used to isolate and identify stem cells which are genes and their protein products are defined as Stem cell markers.

  • Track 11-1Prognostic Biomarkers
  • Track 11-2Predictive Biomarkers
  • Track 11-3Pharmacodynamic Biomarkers
  • Track 11-4Molecular Biomarkers
  • Track 11-5Genomic Biomarkers
  • Track 11-6Cellular Biomarkers
  • Track 11-7Imaging Biomarkers

Designing and developing a supportive medical product with the aid of trending technology to create a solution to the problems faced by the individuals with the impairments in the functional areas like mobility, communications, hearing, vision, and cognition is studied under the subject Rehabilitation Engineering. In contrast, the rehabilitation engineering gives a supportive mechanism for the humans with functional impairments, whereas regenerative medicine tries out to bring back the disabled organ to the original form.

  • Track 12-1Medical Implants & Prosthetics
  • Track 12-2Artificial Organs
  • Track 12-3Prosthetic Cardiac Valves
  • Track 12-4Artificial Lung (oxygenator)
  • Track 12-5Bio Artificial Windpipe
  • Track 12-6Artificial Kidney (Dialyser membrane)
  • Track 12-7Tooth Regeneration
  • Track 12-8Artificial Blood
  • Track 12-9Artificial Heart
  • Track 12-10Artificial Skin
  • Track 12-11Reconstructive Surgery

It has been stated that stem cells have an ability to produce a large number of cells which in turn helps in forming the destroyed tissue or an organ. In contrast, stem cells can also be aided in repairing the damaged organs, in which the mechanism carries out in two different options: support mechanism and replace option. The support mechanism of the stem cell is regeneration or the regrowth of the tissue or organ cells avoiding detrimental fibrosis. The replace option of the stem cell is to transplant the stem cell.

  • Track 13-1The Seeds of Regeneration
  • Track 13-2Cell transplantation Therapy
  • Track 13-3Stem Cells to Liver Tissues
  • Track 13-4Stem Cell Exosomes
  • Track 13-5Hematopoietic Stem Cell Homing
  • Track 13-6Mesenchymal stem cells: harnessing cell plasticity

An experimental technique which uses the genetic cell in the modification of the stem cells in the treatment or prevention of the disease is referred to as the combined Gene and Stem cell therapy. The therapy in general influences the course of different genetic and multi factorial diseases at the DNA/RNA level. The stem cells used in the gene therapy is a valid one which has a complex consequence for treating a variety of diseases, where most don’t have a cure.

  • Track 14-1Stem cell secretome
  • Track 14-2Immunological Changes in the stem cell
  • Track 14-3Cord Blood Stem Cell
  • Track 14-4Disease modeling and drug development
  • Track 14-5Organ synthesis
  • Track 14-6Tissue repair
  • Track 14-7Clinical trial
  • Track 14-8Challenges in reprogramming cells to pluripotency
  • Track 14-9Genes used to produce iPSCs
  • Track 14-10Development of regenerative treatment models
  • Track 14-11Embryonic stem-cell controversy
  • Track 14-12Cell Line Development
  • Track 14-13Tissue Science & Regenerative Medicine
  • Track 14-14Molecular Basis of Epigenetics
  • Track 14-15Cardiovascular Cell Therapy Research
  • Track 14-16Somatic Cell Therapy

Cancer stem cells (CSCs) are the cancer cells found within tumors or haematological regions that possess characteristics related to the normal stem cell. Cancer stem cells specifically have an ability to give rise to all cell types found in a particular cancer sample. CSCs are tumorigenic which form tumors cells; they generate tumors by self-renewal or rapid division of the cells differentiating into multiple cell type. These cells give rise to new tumors by metastasis and relapse caused by hypothesizing    the stem cells to persist in tumors as a distinct population.

 

  • Track 15-1Single Human Melanoma Cells
  • Track 15-2Tumor propagation models
  • Track 15-3cancer stem cell model
  • Track 15-4Stochastic model
  • Track 15-5Epithelial-Mesenchymal Transition
  • Track 15-6Heterogeneity Markers
  • Track 15-7Hypotheses Mutation

3D printing is a 3-dimentional printing machine which gives the information of a 2D image in the form of 3D object. The layer of materials to form a 3D object is controlled by the computer by providing geometry of the object. 3D Bioprinting aids Tissue Engineering by providing an in depth information of the image and structure analysis of the image, which helps in solving the critical problems. Biofabrication is referred to the production of artificial tissues or organs to address health challenges in medicine. It often uses the principle of 3D Bioprinting to form cells, gels and fibres into an organ.

 

  • Track 16-13D Printing for Life science
  • Track 16-2Material consideration for 3D Printing in Tissue Engineering
  • Track 16-3Importance of 3D Bio printing
  • Track 16-4Additive Manufacturing and Other Platforms for 3D-Printing
  • Track 16-53D-Printing, Biofabrication and Bioprinting using Microfluidics
  • Track 16-6Bioinks
  • Track 16-7Engineered Tissue
  • Track 16-8Innovative Development in 3D-Bioprinting
  • Track 16-9Intelligent Biomaterials
  • Track 16-10Synthetic Biology Approaches for Tissue Engineering and Regenerative Medicine